Follow
Sandrine Sagan
Sandrine Sagan
DR CNRS, UPMC, ENS
Verified email at upmc.fr
Title
Cited by
Cited by
Year
Cell-penetrating peptides: 20 years later, where do we stand?
C Bechara, S Sagan
FEBS letters 587 (12), 1693-1702, 2013
10882013
Translocation and endocytosis for cell-penetrating peptide internalization
CY Jiao, D Delaroche, F Burlina, ID Alves, G Chassaing, S Sagan
Journal of Biological Chemistry 284 (49), 33957-33965, 2009
4042009
Cell‐surface thiols affect cell entry of disulfide‐conjugated peptides
S Aubry, F Burlina, E Dupont, D Delaroche, A Joliot, S Lavielle, ...
The FASEB Journal 23 (9), 2956-2967, 2009
1882009
The human sperm protein PH-20 has hyaluronidase activity
M Gmachl, S Sagan, S Ketter, G Kreil
FEBS letters 336 (3), 545-548, 1993
1871993
Different membrane behaviour and cellular uptake of three basic arginine-rich peptides
A Walrant, I Correia, CY Jiao, O Lequin, EH Bent, N Goasdoué, ...
Biochimica et biophysica acta (BBA)-biomembranes 1808 (1), 382-393, 2011
1842011
Membrane interaction and perturbation mechanisms induced by two cationic cell penetrating peptides with distinct charge distribution
ID Alves, N Goasdoué, I Correia, S Aubry, C Galanth, S Sagan, S Lavielle, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1780 (7-8), 948-959, 2008
1652008
Tryptophan within basic peptide sequences triggers glycosaminoglycan‐dependent endocytosis
C Bechara, M Pallerla, Y Zaltsman, F Burlina, ID Alves, O Lequin, ...
The FASEB Journal 27 (2), 738-749, 2013
1492013
Lipid reorganization induced by membrane-active peptides probed using differential scanning calorimetry
P Joanne, C Galanth, N Goasdoué, P Nicolas, S Sagan, S Lavielle, ...
Biochimica et Biophysica Acta (BBA)-Biomembranes 1788 (9), 1772-1781, 2009
1452009
Quantification of the cellular uptake of cell‐penetrating peptides by MALDI‐TOF mass spectrometry
F Burlina, S Sagan, G Bolbach, G Chassaing
Angewandte Chemie 117 (27), 4316-4319, 2005
1412005
N-and Cα-methylation in biologically active peptides: synthesis, structural and functional aspects
S Sagan, P Karoyan, O Lequin, G Chassaing, S Lavielle
Current medicinal chemistry 11 (21), 2799-2822, 2004
1312004
Isolation of dermenkephalin from amphibian skin, a high‐affinity (δ‐selective opioid heptapeptide containing a D‐amino acid residue
A Mor, A Delfour, S Sagan, M Amiche, P Pradelles, J Rossier, P Nicolas
FEBS letters 255 (2), 269-274, 1989
1311989
Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors.
S Sagan, G Chassaing, L Pradier, S Lavielle
Journal of Pharmacology and Experimental Therapeutics 276 (3), 1039-1048, 1996
1301996
Peptide‐grafted nanodiamonds: preparation, cytotoxicity and uptake in cells
S Vial, C Mansuy, S Sagan, T Irinopoulou, F Burlina, JP Boudou, ...
ChemBioChem 9 (13), 2113-2119, 2008
1242008
The role of tryptophans on the cellular uptake and membrane interaction of arginine-rich cell penetrating peptides
ML Jobin, M Blanchet, S Henry, S Chaignepain, C Manigand, S Castano, ...
Biochimica et Biophysica Acta (BBA)-Biomembranes 1848 (2), 593-602, 2015
1202015
Relationships between membrane binding, affinity and cell internalization efficacy of a cell-penetrating peptide: penetratin as a case study
ID Alves, C Bechara, A Walrant, Y Zaltsman, CY Jiao, S Sagan
PloS one 6 (9), e24096, 2011
1182011
Quantitative fluorescence spectroscopy and flow cytometry analyses of cell-penetrating peptides internalization pathways: optimization, pitfalls, comparison with mass …
F Illien, N Rodriguez, M Amoura, A Joliot, M Pallerla, S Cribier, F Burlina, ...
Scientific Reports 6 (1), 36938, 2016
1172016
A direct approach to quantification of the cellular uptake of cell-penetrating peptides using MALDI-TOF mass spectrometry
F Burlina, S Sagan, G Bolbach, G Chassaing
Nature protocols 1 (1), 200-205, 2006
1092006
Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
A Walrant, S Cardon, F Burlina, S Sagan
Accounts of chemical research 50 (12), 2968-2975, 2017
1082017
Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
M Amiche, S Sagan, A Mor, A Delfour, P Nicolas
Molecular pharmacology 35 (6), 774-779, 1989
1061989
Tracking a new cell-penetrating (W/R) nonapeptide, through an enzyme-stable mass spectrometry reporter tag
D Delaroche, B Aussedat, S Aubry, G Chassaing, F Burlina, G Clodic, ...
Analytical chemistry 79 (5), 1932-1938, 2007
1052007
The system can't perform the operation now. Try again later.
Articles 1–20